Luxiq is a topical steroid indicated for the relief of corticosteroid-responsive skin conditions of the scalp (scalp psoriasis). It contains anti-inflammatory, antipruritic, and vasoconstrictive properties. It is thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins.
Cobrek Pharmaceuticals, a partner of Perrigo, was approved for generic Luxiq Foam on November 28, 2012.
For more information call (800) 719-9260 or visit www.perrigo.com